Democrats Choosing Less Risky Path on Drug Prices
Experts say recent compromises could create less harm in balancing innovation with profits.
Divided Democrats Lurch Toward Vote on $1 Trillion Infrastructure Bill
Progressives appeared ready to support the bill in exchange for a commitment from moderates to eventually back a separate $1.85 trillion social safety net bill that was put on hold on Friday.
Pfizer Says Its Antiviral Pill Is Highly Effective in Treating Covid
Pfizer’s is the second pill to show effectiveness against Covid-19, and it is the first purpose-built to attack the virus that causes the disease.
Elizabeth Holmes Trial Exposes Investors’ Lack of Due Diligence
Start-up investors have often suspended skepticism while chasing a hot deal. The trial of Ms. Holmes, the founder of Theranos, has put that behavior under the spotlight.
U.K. Authorizes Merck’s Antiviral Pill for Covid-19
The authorization of Merck’s easy-to-use Covid treatment, molnupiravir, is a step toward taming the pandemic.
Who Can Make mRNA Vaccines?
Many health advocates say a key solution is to make the shots in the regions that still don’t have them. I wanted to know whether there were companies that could do it.
Democrats Reach Deal to Control Drug Prices in Bill
The provision would, for the first time, allow the government to negotiate prices for some medicines covered by Medicare.
Democrats Reach Deal to Control Drug Prices in Social Policy Bill
The provision would, for the first time, allow the government to negotiate prices for some medicines covered by Medicare.
Opioid Makers Win Major Victory in California Trial
In one of the first cases to be brought against drug manufacturers over the crisis, a judge ruled that there was “simply no evidence” the companies were liable in the epidemic.
Manchin Raises Doubts on Safety Net Bill, Complicating Path to Quick Vote
Senator Joe Manchin III of West Virginia, a crucial Democratic swing vote, demanded more time to evaluate the economic and fiscal impact of the $1.85 trillion bill.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.